Valuation: Electromed, Inc.

Market Cap 350M 306M 283M 264M 497M 33.06B 508M 3.4B 1.31B 16.31B 1.31B 1.28B 56.62B P/E 2026 *
34.7x
P/E 2027 * 28.5x
Enterprise Value 350M 306M 283M 264M 497M 33.06B 508M 3.4B 1.31B 16.31B 1.31B 1.28B 56.62B EV / Sales 2026 *
4.75x
EV / Sales 2027 * 4.18x
Free-Float
78.56%
Yield 2026 *
-
Yield 2027 * -
1 day-0.37%
1 week+10.27%
Current month+12.64%
1 month+15.99%
3 months+74.56%
6 months+47.38%
Current year+45.91%
1 week 38.48
Extreme 38.4801
43.05
1 month 35.61
Extreme 35.61
43.05
Current year 23.01
Extreme 23.01
43.05
1 year 17.73
Extreme 17.73
43.05
3 years 8.8
Extreme 8.8
43.05
5 years 8.75
Extreme 8.75
43.05
10 years 3.38
Extreme 3.38
43.05
Manager TitleAgeSince
Chief Executive Officer 61 30/06/2023
Director of Finance/CFO 44 13/11/2022
Compliance Officer - 31/08/2023
Director TitleAgeSince
Chairman 69 30/06/2023
Director/Board Member 76 20/11/2014
Director/Board Member 57 14/08/2019
Date Insider Type Main position Quantity % Market Cap.
06-07Fiscal year

Chief Executive Officer

29,100 0.3514%
06-03Fiscal year

Chief Financial Officer

31,003 0.3744%
05-14Fiscal year

Chairman

120,000 1.4501%
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%+10.27%+93.22%+296.72% 350M
-0.96%+6.82%+23.65%-3.91% 188B
-1.63%-0.31%-26.04%+17.54% 144B
-0.71%+6.96%-3.10%-20.24% 136B
-1.41%-5.46%-59.86%-20.30% 64.63B
-1.58%+4.89%+16.61%-3.32% 52.5B
-0.06%-1.07%-27.43%-34.15% 43.4B
-1.18%+4.15%+11.79%+9.71% 37.52B
-0.12%+2.62%+5.02%+37.52% 36.22B
-2.05%+0.89%-13.20%-20.86% 29.59B
Average -1.05%+4.74%+2.07%+25.87% 73.26B
Weighted average by Cap. -1.09%+5.68%-4.96%-3.73%

Financials

2026 *2027 *
Net sales 73.6M 64.44M 59.49M 55.56M 105M 6.96B 107M 716M 276M 3.43B 276M 270M 11.92B 83.6M 73.2M 67.58M 63.1M 119M 7.9B 121M 813M 314M 3.9B 314M 307M 13.54B
Net income 10.53M 9.22M 8.51M 7.95M 14.97M 996M 15.31M 102M 39.55M 491M 39.56M 38.69M 1.71B 12.83M 11.24M 10.37M 9.69M 18.24M 1.21B 18.65M 125M 48.19M 599M 48.19M 47.14M 2.08B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
179
Date Price Change Volume
30/06/26 US$42.49 +0.61% 2,722
29/06/26 US$42.23 +1.86% 97,113
26/06/26 US$41.46 +3.52% 201,127
25/06/26 US$40.05 +2.38% 89,093
24/06/26 US$39.12 +1.53% 152,542
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
42.23USD
Average target price
40.33USD
Spread / Average Target
-4.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock